Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2630 |
|
Actual shortage: | 256 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2365 (90%) | |
Discontinuation Reports |
249 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 246 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
318 (11%) |
|
Overdue reports |
22 (8%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-RISPERIDONE | 0.25MG | TABLET | Resolved | 2022-06-16 | 2022-09-08 | 162861 |
TEVA-PROPRANOLOL | 10MG | TABLET | Resolved | 2022-06-30 | 2022-08-16 | 163903 |
TEVA-PROPRANOLOL | 80MG | TABLET | Resolved | 2022-06-30 | 2022-08-16 | 163906 |
TEVA-NAPROXEN | 250MG | TABLET | Resolved | 2022-06-30 | 2022-08-19 | 163909 |
TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2022-06-30 | 2023-04-28 | 163912 |
TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2022-06-30 | 2023-06-09 | 163915 |
TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2022-06-30 | 2023-04-28 | 163918 |
TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2022-06-30 | 2023-06-27 | 163921 |
TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2022-06-30 | 2023-04-28 | 163927 |
TEVA-OLANZAPINE | 2.5MG | TABLET | Resolved | 2022-06-30 | 2022-08-09 | 163930 |
TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2022-06-30 | 2022-08-20 | 163933 |
TEVA-RISEDRONATE | 5MG | TABLET | Resolved | 2022-06-30 | 2022-12-08 | 163948 |
TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2022-06-30 | 2022-10-18 | 163954 |
TEVA-RISEDRONATE | 150MG | TABLET | Resolved | 2022-06-30 | 2024-02-06 | 163957 |
ACT LEVOFLOXACIN | 500MG | TABLET | Resolved | 2022-07-25 | 2023-04-28 | 165430 |
ACT LEVOFLOXACIN | 250MG | TABLET | Resolved | 2022-07-25 | 2023-04-28 | 165433 |
TEVA-CODEINE | 30MG | TABLET | Resolved | 2022-07-25 | 2022-12-22 | 165436 |
TEVA-LOPERAMIDE | 2MG | TABLET | Resolved | 2022-07-25 | 2022-10-01 | 165441 |
TEVA-CODEINE | 15MG | TABLET | Resolved | 2022-07-25 | 2022-12-22 | 165444 |
TEVA-EMTEC-30 | 30MG 300MG | TABLET | Resolved | 2022-07-25 | 2022-09-23 | 165450 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TRANDOLAPRIL | 0.5MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120021 |
TEVA-TRANDOLAPRIL | 1MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120024 |
TEVA-TRANDOLAPRIL | 2MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120027 |
TEVA-TRANDOLAPRIL | 4MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120030 |
TEVA-PREGABALIN | 75MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120033 |
ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
TEVA-QUININE | 200MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125976 |
TEVA-CEPHALEXIN | 500MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125979 |
ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |
ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 |